Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Skye Bioscience, Inc. is a clinical-stage biotechnology company. The Company is focused on development of next-generation molecules that modulate G-protein coupled receptors to treat obesity, overweight, and related conditions. The Company’s lead candidate, nimacimab, is a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1 (CB1). The Company is also focused on its Phase IIa clinical trial, CBeyond, for nimacimab. The CBeyond clinical trial includes approximately 136 patients, 16 clinical trial sites and a combination arm with a GLP-1 receptor agonist to assess differences in weight loss, body composition, and other attributes. The CB1 receptor is one of the receptors in the endocannabinoid system (ECS) and plays a significant role both in the central nervous system (CNS) and peripheral tissues. The Company's Phase II study in obesity for nimacimab, is a negative allosteric modulating antibody that peripherally inhibits CB1.
Find out what a historical investment in Skye Bioscience, Inc. Common Stock would be worth today using our SKYE stock calculator.
Buying SKYE shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Skye Bioscience, Inc. Common Stock in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in SKYE
What is the ticker symbol of Skye Bioscience, Inc. Common Stock?
The ticker symbol for Skye Bioscience, Inc. Common Stock is SKYE.
How much is one share of SKYE?
One share of SKYE is valued at $0.00 as of 20 November 2026.
What is the market capitalisation of Skye Bioscience, Inc. Common Stock SKYE?
As of 20 November 2026 Skye Bioscience, Inc. Common Stock has a market cap of $4.56M.
What is the 52-week high for Skye Bioscience, Inc. Common Stock stock?
The Skye Bioscience, Inc. Common Stock 52-week high stock price is $11.04.
What is the 52-week low for Skye Bioscience, Inc. Common Stock stock?
The Skye Bioscience, Inc. Common Stock 52-week low stock price is $0.50.
Can I buy SKYE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy SKYE shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SKYE on Stake
Buy SKYE from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of SKYE from only US$10 with fractional shares